Lucigen Corporation


BiotechProfiles™ is the premier resource for jobs, company information, professional networking and productivity tools in the Madison, Wisconsin biotechnology and medical device industry. Recognized as one of the premier emerging biotechnology clusters in the U.S., this robust industry sector comprises nearly 10,000 employees in approximately 150 companies. BiotechProfiles also maintains a unique directory of the largest 250 pharmaceutical companies worldwide, including business development contacts whenever available. This tool is indispensable for executives pursuing strategic alliances and technology licenses.
Designed as a suite of easy to use, searchable databases that are continually updated, BiotechProfiles serves the needs of biotech business development and operational executives in early stage companies, as well as the general public. With these tools you can quickly bypass the data collection and screening stage and immediately focus on solving your strategic partnering or operational needs. We've assembled your background data for you!
  Next »

BiotechProfiles is also the premier site for data on Biotechnology Companies in Madison Wisconsin, Biotechnology Jobs in Madison Wisconsin

Biotechnology Companies in Madison Wisconsin; Biotechnology Jobs in Madison Wisconsin
  « Previous | Next »

Biotechnology Business Development, Partnering and Strategic Alliances

Biotechnology Business Development, Partnering and Strategic Alliances
  « Previous | Next »

Madison Biotechnology Companies; Madison Biotechnology Jobs

Madison Biotechnology Companies; Madison Biotechnology Jobs
  « Previous | Next »

List or rank of Largest Pharmaceutical Companies Worldwide

List of rank of Largest Pharmaceutical Companies Worldwide
  « Previous


Company Profile

Lucigen Corporation, a unit of LGC since 2018, focuses on developing new, more effective products and technologies for gene cloning, genomics, and protein expression. The company's patented CloneSmart® technology dramatically improves DNA cloning reliability and efficiency, allowing successful cloning of genes that have been impossible to clone with standard methods. The revolutionary BigEasy® Linear Cloning Kits were developed to clone the “unclonable.”

Lucigen’s exclusive Random Shear BAC Library Cloning Services provide complete, unbiased, gap-free genomic libraries, and are being used by genome researchers around the world. The company recently developed proprietary methods that achieve the ultimate goal in cloning: the ability to clone genes and the entire genome directly from a few isolated cells. This quantum-leap capability, called the NanoClone® technology, represents a billion-fold improvement in cloning efficiency as compared to standard methods.

Lucigen has introduced an initial group of novel enzymes —the first-ever thermostable, bacteriophage DNA polymerase, PyroPhage® 3173 DNA Polymerase, that promises more accurate and efficient DNA amplification (research, diagnostics, and drug discovery markets); and thermostable carbohydrases for greater yields in producing bioethanol for fuels, as well as for greater efficiency in many other industrial processes (textiles, food production, etc.)
Business Sectors
Pharmaceuticals   Human Diagnostics
Med or Lab Devices   Lab Reagents or Services
Drug Manufacturing   Food & Agribusiness  
CRO   Bioinformatics or Software  
Company History
Lucigen was acquired by LGC Limited in February 2018. LGC is a private, London based international firm with over 2300 employees.
Lucigen Corporation
Address 2905 Parmenter Street
[Map] Middleton
Phone 608-831-9011
Fax 608-831-9012
Website Link
Head Ralph Kauten
Company Statistics
Global Headcount 70
Local Headcount 70
Year Founded 1998
Ownership Subsidiary
Stock Exchange

Parent Company
Divisional Level
Senior Level LGC Limited [London, UK]
Global Headcount 2300
Website Link
Stock Exchange
Reference Documents
2018 - Lucigen acquired by LGC [View]
2014 - Lucigen Advances Ebola Test [View]
2014 - Lucigen Pursues Ebola Test [View]
2013 - Lucigen Advances Diagnostics Business [View]
2012 - Lucigen Gets Grant for First Diagnostic Test [View]
2003 - Lucigen Profiled [View]